Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 9Sarcoma 4Genitourinary 3Gastrointestinal 3Head & Neck 2Endocrine 2Dermatologic 2Breast 2Thoracic 1NET 1CNS 1

Conditions

Breast Neoplasms 379Triple Negative Breast Neoplasms 61Ovarian Neoplasms 46Prostatic Neoplasms 35Colorectal Neoplasms 35Neoplasms 28Carcinoma, Non-Small-Cell Lung 27Endometrial Neoplasms 24Lung Neoplasms 22Neoplasm Metastasis 21Uterine Cervical Neoplasms 19Melanoma 18Stomach Neoplasms 17Pancreatic Neoplasms 16Squamous Cell Carcinoma of Head and Neck 15Carcinoma, Renal Cell 14Urinary Bladder Neoplasms 13Sarcoma 12Head and Neck Neoplasms 12Esophageal Neoplasms 11Colonic Neoplasms 10Advanced Breast Cancer 9Small Cell Lung Carcinoma 8Carcinoma, Transitional Cell 8Anatomic Stage I Breast Cancer AJCC v8 8Liver Neoplasms 7Kidney Neoplasms 7Cholangiocarcinoma 7Carcinoma, Hepatocellular 6Brain Neoplasms 6

Interventions

tivozanib 1atezolizumab 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Breast × 30 days × Clear all
NCT05000294 2026-06-05

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

University of Florida

Phase 1/2 Recruiting
29 enrolled
BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03180294 2026-05-19

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NRG Oncology

Phase 2 Completed
230 enrolled 24 charts
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡